High-yield dividend stocks have been gaining momentum ahead of potential Fed rate cuts. While sticky inflation and possible ...

Pfizer's latest COVID booster targets Omicron JN.1. Learn who should get it and why it’s essential for protection.

A Las Vegas woman is not only fighting for her life, but also against a pharmaceutical company after her tumors could be ...

We recently compiled a list of the Jim Cramer Talked About These 11 Stocks Recently. In this article, we are going to take a ...

Though the strategic shift allows pharma to offer integrated health solutions, diversify revenue and improve patient outcomes ...

The Trump presidency and mooted ascension of prominent vaccination opponent Robert F. Kennedy Junior to head the US ...

Byondis B.V., an independent clinical stage biopharmaceutical company creating innovative targeted medicines for patients ...

The agency's openness to a targeted pivotal study shows it’s still willing to consider accelerated clearance for Duchenne ...

In another sign of biopharma's waning interest in the traditional ex vivo gene therapy approach, CSL Behring is shutti | CSL ...

Biotech-stock investing has one tough test for success - and it's about to get easier ...

But the incumbents look set to fight to hold on to the market, with Alnylam Pharmaceuticals sharing early-phase data on its ...

MedGenome: Genomic tests, now becoming as routine as pathology and imaging, are poised to enhance early detection of both ...